Scientists Pushing Back Warnings Shake Microplastics Debate
A growing chorus of scientists pushing back warnings about microplastics challenges a decade of health scare headline...
Using Credit Cards Smartly For Cash Back
Find out how to use credit cards smartly for cash back rewards and increase your financial benefits. Start optimizing today!
22,942 articles
Billion Floods Back Into Crypto Funds, Reversing Bleed
Digital asset funds snapped a five-week bleed with a $1 billion inflow, led by Bitcoin and Ethereum, signaling a caut...
Google OpenAI Employees Back Anthropic in AI Policy Fight
Rival AI employees have filed an amicus brief backing Anthropic in a Pentagon-led dispute over a supply-chain risk de...
Gold Back Under $5,000: Is This ETF the Trigger for a Move
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
Piper Sandler Cuts Upstart Target as Q1 Miss Tests Outlook
Piper Sandler trimmed its Upstart price target to $46 after a softer Q1 EBITDA print, but kept an Overweight rating a...
AI Push Slashes Back-Office Jobs at Standard Chartered Bank
Standard Chartered Bank unveils a major automation plan with a 15% cut to back-office roles as it pivots to AI-driven...
Ripple ‘Delisting’ Rumors Debunked: DTCC Collateral Lists
A DTCC collateral update did not blacklist XRP. The market briefly dumped XRP for other assets, but analysts say the ...
MiB: Mamoon Hamid, Kleiner Perkins on AI Investing
In this in-depth piece, we explore Mamoon Hamid’s approach to AI investing at Kleiner Perkins, the lessons from early...
These Missing Pieces Holding Bitcoin Back, Analysts Say
Bitcoin has rebounded about 10% from a multi-year trough, but three on-chain signals must align before a sustained ra...
Base Creator Jesse Pollak Steps Back From App Leadership
A high-profile shift at Base has changed the project’s direction. Jesse Pollak is stepping back from app leadership t...
ExxonMobil Chevron: Which Dividend Is Best for Lifetime Income
ExxonMobil and Chevron are two of the most trusted names for dividend investors. This guide breaks down which could d...
AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status